Banking Sector
Biopharmaceuticals
Stock Picks

Jim Cramer Says There’s A ‘Chance To Pounce’ On These 3 Stocks

These 3 stocks have been beaten down this week, but Cramer says the market’s trash can be your treasure.

Read More
Gold
Gold Stocks
One Hot Stock
TradersPro Alerts

U.S. Gold Corp. (USAU) Buy Target – $1.10

Trade Setup Buy Target – $1.10 Sell Target – TradersPro Sell Signal U.S. Gold Corp. operates as a gold exploration and development company in the United States. It explores for gold, copper, silver, and zinc minerals. The company’s properties include the Copper King project located in southeast Wyoming; and Keystone project, an exploration property on […]

Read More
Consumer Staples
Defensive Stocks
Dividends
Fibonacci Retracement
Fundamental Analysis
Risk
Technical Analysis
Value Investing
Value Stocks

PG is a dividend king – but that doesn’t mean you should buy it now

In the last week, one of the interesting threads that I’ve seen come out of the market’s latest run of volatility is a wave of investor rotation into “defensive” sectors, which usually includes Utilities, Consumer Staples and other pockets of the market that investors tend to think of as safe havens when market uncertainty is […]

Read More
Consulting
One Hot Stock
TradersPro Alerts

StarTek, Inc. (SRT) Buy Target – $7.00 or better

Trade Setup Buy Target – $7.00 or better Sell Target – TradersPro Sell Signal StarTek, Inc. operates as a business process outsourcing company that provides omnichannel customer interactions and technology back-office support solutions. It primarily offers customer engagement consulting, omnichannel engagement, social media, customer intelligence analytics, scientific research, back office, and receivables management services under […]

Read More
Apple
Biopharmaceuticals
Biotech
China
Daily Rundown
Donald Trump
Federal Reserve
Gaming
Tech Stocks
Trade War
Transportation

The Biggest Surprise From Apple’s Event Yesterday – Lower Prices

Plus, Trump bashed the Fed on Twitter again, China just exempted some products from tariffs, and shares of GameStop are tanking.

Read More
Auto Industry
Discretionary
Fibonacci Retracement
Fundamental Analysis
Risk
Tariffs
Technical Analysis
Value Investing
Value Stocks
Value Traps

Is it time to start taking GT’s bargain price seriously?

If you’ve been reading my daily posts for very long at all, you should be pretty used to seeing me evaluate companies throughout the market on the basis of both their fundamental strength as well as their value proposition. That’s because in the search for good investing opportunities, I’ve learned to rely on a few […]

Read More
Airlines
Auto Industry
Biotech
China
Daily Rundown
Federal Reserve
Gold
IPO
Tobacco
Trade War

Why Citigroup Says Gold Could Jump To $2,000 An Ounce

Plus, Moody’s downgraded Ford to junk, China’s Huawei dropped a lawsuit against the U.S., WeWork is moving ahead with its IPO, and Wendy’s is bringing back breakfast.

Read More
Digital Imaging
One Hot Stock
Surveillance
TradersPro Alerts

Digital Ally, Inc. (DGLY) – Buy Target – $1.75 or better

Trade Setup Buy Target – $1.75 or better Sell Target – TradersPro Sell Signal Digital Ally, Inc. produces and sells digital video imaging and storage products for use in law enforcement, security, and commercial applications in the United States and internationally. Its digital audio/video recording, storage, and other products include an in-car digital audio/video recorder […]

Read More
Biopharmaceuticals
Biotech
Fibonacci Retracement
Fundamental Analysis
HeathCare
Pharmaceuticals
Technical Analysis
Trade War
Value Investing
Value Stocks

GILD’s value proposition is too good to pass up – isn’t it?

Progress on the trade front has given the market a new set of momentum over the past couple of weeks – enough that the major indices are nearing the all-time highs they set at the end of July. Even so, the unpredictability associated with tariff news and the trade war itself has resulted in a […]

Read More
Daily Perspective
IPO

The Biggest IPOs Hitting the Market This Week

No. 6: Satsuma Pharmaceuticals Inc. (STSA) Satsuma is a San Francisco-based pharmaceutical firm developing a dry-powder nasal spray to treat migraines. The product candidate — STS101 — can be quickly self-administered with a proprietary pre-filled, single-use, nasal delivery device. The company began a Phase 3 electronic medical records and genomics (eMERGE) trial for STS101 this […]

Read More